Levorphanol Dl-Form

Levorphanol Dl-Form Brand names, Levorphanol Dl-Form Analogs

Levorphanol Dl-Form Brand Names Mixture

No information avaliable

Levorphanol Dl-Form Chemical_Formula

C₁₇H₂₃NO

Levorphanol Dl-Form RX_link

http://www.rxlist.com/cgi/generic2/levorphanol.htm

Levorphanol Dl-Form fda sheet

Levorphanol Dl-Form msds (material safety sheet)

Levorphanol_Dl-Form MSDS

Levorphanol Dl-Form Synthesis Reference

Woods LA, et al. J Pharmacol Exp Ther. 1958 Sep;124(1):1-8.

Levorphanol Dl-Form Molecular Weight

257.371 g/mol

Levorphanol Dl-Form Melting Point

198-199 ^oC

Levorphanol Dl-Form H₂O Solubility

1840 mg/L

Levorphanol Dl-Form State

Solid

Levorphanol Dl-Form LogP

3.986

Levorphanol Dl-Form Dosage Forms

Tablet

Levorphanol Dl-Form Indication

For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate

Levorphanol Dl-Form Pharmacology

Levorphanol is a potent synthetic opioid analgesic indicated for the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate. Levorphanol is similar to morphine in its actions, however it is up to 8 times more potent than morphine. Levorphanol produces a degree of respiratory depression similar to that produced by morphine at equianalgesic doses, and like many mu-opioid drugs, levorphanol produces euphoria or has a positive effect on mood in many individuals.

Levorphanol Dl-Form Absorption

Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.

Levorphanol Dl-Form side effects and Toxicity

LD₅₀=150 mg/kg (orally in rats). Signs of overdose include nausea, emesis, dizziness, respiratory depression, hypotension, urinary retention, cardiac arrhythmias, allergic reactions, skin rash, and uticaria.

Levorphanol Dl-Form Patient Information

No information avaliable

Levorphanol Dl-Form Organisms Affected

Humans and other mammals